Trius CEO: FDA Is Incredibly Helpful Trius Therapeutics CEO Jeff Styne discusses the support for his company's antibiotic drug Tedizolid, and the state of the biotech industry.
July 11, 2013 - CNBC
Turkey tests find reasons for concern In its first lab analysis of ground turkey products, Consumer Reports found potential disease-causing organisms in most of the samples it tested, more than half of which proved resistant to more than three antibiotic drug classes.
July 8, 2013 - The Buffalo News